H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30

1 week ago 7

Noor Ul Ain Rehman

Sun, December 21, 2025 astatine 8:57 AM CST 2 min read

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is 1 of the champion small headdress stocks to bargain with immense upside potential. H.C. Wainwright lifted the terms people connected BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) to $32 from $30 connected December 15, and reaffirmed a Buy standing connected the stock. The steadfast told investors that the support of Orladeyo successful the pediatric diligent colonisation marks a important origin for the standing update, arsenic Orladeyo is the archetypal and lone targeted oral prophylactic therapy approved for usage successful patients ages 2 to 12 with hereditary angioedema.

Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared connected Monday

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) announced connected December 12 that the FDA approved its New Drug Application (NDA) for the usage of an oral pellet formulation of once-daily ORLADEYO (berotralstat) for prophylactic therapy successful pediatric patients with hereditary angioedema aged 2 to <12 years. The lone targeted attraction options for patients nether property 12, until now, were administered either intravenously oregon done subcutaneous injection, which could beryllium burdensome for younger patients and their caregivers.

Management further reported that the FDA granted support to a capsule formulation of ORLADEYO for prophylaxis for the prevention of HAE attacks successful big and pediatric patients 12 years and older successful December 2020, which present holds support successful implicit 45 countries crossed the globe.

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is simply a biotechnology institution that provides structure-guided cause plan to make oral small-molecule and macromolecule therapeutics to people difficult-to-treat uncommon diseases.

While we admit the imaginable of BCRX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.